According to research report the Thrombectomy Devices Market is expected to reach USD 1.45 Billion by 2022 growing at a CAGR of 6.7%.
Ask For PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801
This
large thrombectomy devices market share is mainly attributed to factors
such as increasing prevalence of cardiovascular diseases across major
markets, higher prevalence of thrombotic diseases among geriatric
individuals, procedural benefits offered by mechanical thrombectomy in
cardiac surgeries and growing preference of surgeons for image-guided
and minimally invasive cardiac surgeries.
On the basis of
application, the global thrombectomy procedure market is segmented into
neurovascular, cardiovascular, and peripheral vascular applications. The
cardiovascular applications segment accounted for the largest share of
the market in 2016. The large share of this segment is attributed to the
increasing prevalence of cardiovascular diseases, procedural benefits
offered by mechanical thrombectomy in cardiac surgeries, higher
prevalence of thrombotic diseases among geriatric individuals, and
growing preference of surgeons for image-guided and minimally invasive
cardiac surgeries.
On the basis of end users, the global
thrombectomy procedure market is segmented into hospitals & surgical
centers, ambulatory surgical centers, research laboratories &
academic institutes, and other end users. The highest CAGR of the
ambulatory surgical centers segment is mainly attributed to increasing
availability of reimbursement for thrombectomy procedures in outpatient
settings, ongoing advancements in minimally invasive surgical
techniques, increasing number of image-guided surgeries performed at
ASCs, and rising market demand for miniaturized therapeutic devices.
On
the basis of type, the global thrombectomy devices market is segmented
into aspiration, mechanical/fragmentation, rheolytic/hydrodynamic, and
ultrasonic thrombectomy devices. The mechanical/fragmentation
thrombectomy devices segment accounted for the largest share of the
market in 2016. This large share is attributed to the ongoing
commercialization of mechanical thrombectomy products, favorable
reimbursement scenario, established therapeutic efficacy, growing market
demand for stent retrievers among medical professionals, and rising
end-user preference for minimally invasive thrombectomy procedures.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222966801
some
of the major players in the global thrombectomy devices market are
Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific
Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.),
Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards
Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and
Teleflex Incorporated (U.S.).